New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
05:30 EDTNSRGY, VRX, AGNValeant to sell filler, toxin assets to Nestle for $1.4B in cash
Valeant Pharmaceuticals (VRX) announced that it has entered into an agreement with Nestle S.A. (NSRGY) to sell all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by Valeant for $1.4B in cash. Nestle expects to complete its acquisition of Galderma S.A. in July and would expect to operate the acquired assets through Galderma. The transaction is subject to customary closing conditions, including clearance or early expiration of the waiting period under the Hart-Scott-Rodino Act and is not contingent upon a successful transaction with Allergan (AGN). Valeant believes that this transaction is extremely attractive both to Valeant and Galderma, and dovetails well with the company's announced plans for a transaction with Allergan.
News For VRX;NSRGY;AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2015
05:32 EDTNSRGYNestle confirms FY15 organic growth outlook of around 5%
Subscribe for More Information
05:29 EDTNSRGYNestle reports three-month organic growth of 4.4%, 1.9% real internal growth
Subscribe for More Information
April 16, 2015
11:44 EDTNSRGYNestle continues to streamline its business as competition heats up, WSJ says
Subscribe for More Information
April 14, 2015
06:51 EDTNSRGYNestle in advanced talks to sell Davigel unit to Brakes Group, Reuters reports
Nestle is in advanced discussions for the sale of its Davigel frozen food group to Bain Capital's Brakes Group, Reuters reports, citing a source. A second source says the sale of the deal, which is being handled by Credit Suisse, could raise EUR200M-EUR300M. Reference Link
April 9, 2015
11:39 EDTVRXPershing Square, Valeant, Allergan drop lawsuit over buyout
Subscribe for More Information
April 8, 2015
12:17 EDTVRXOn The Fly: Midday Wrap
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use